Drug pricing reform in the Inflation Reduction Act (IRA) is expected to have a considerable impact on the pharmaceutical industry. What do stakeholders need to know, and how can they prepare? In this webinar, a team of industry experts talk about what the IRA means for pharma.
During this session, we discuss:
- Key provisions that will affect pharma manufacturers
- Potential implications for industry stakeholders
- How the industry can prepare for the IRA's impact
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
